Astal Laboratories (BOM:512600) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512600 Astal Laboratories Ltd BOM:512600
53 GF Score
Price ₹78.74
GF Value ₹139.73
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Astal Laboratories Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

BOM:512600
53GF Score
Astal Laboratories Ltd BOM:512600
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Astal Laboratories (BOM:512600) Overvalued in 2026?

Based on GuruFocus' analysis, Astal Laboratories stock appears to be undervalued. The current stock price of ₹78.74 is trading 43.6% below its estimated GF Value™ of ₹139.73. GuruFocus considers Astal Laboratories to be Possible Value Trap.

Key valuation signals for BOM:512600:

  • Dividends Received:
  • GF Value™: ₹139.73 vs. price of ₹78.74 (43.6% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the BOM:512600 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astal Laboratories Business Description

Address D-1, Motilal Atal Road, Behind Hotel Neelam, Jaipur, RJ, IND, 302001
Astal Laboratories Ltd is an India-based company. The main objects of the company are to manufacture and sales of Pharmaceutical Intermediates and Bulk Drugs. The company has a single segment, i.e., Pharmaceuticals.
53GF Score

Get the complete analysis for BOM:512600

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹78.74
Price
₹139.73
GF Value